English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biogen
+
Technology/Innovation
Bree Gonzales
| Jun 9, 2021
Biogen gets FDA approval for Alzheimer's treatment: 'the first therapy to target the underlying disease process'
+
Community
Carrie Bradon
| Nov 30, 2017
Biogen names new chief financial officer
+
Technology/Innovation
Carrie Bradon
| Nov 27, 2017
Biogen to present at conference this month
+
Regulatory
Nicholas Gueguen
| Jun 11, 2017
European Commission OKs Spinraza to fight spinal muscular atrophy
+
Technology/Innovation
Jeff Gantt
| Dec 14, 2016
Biogen presents PRIME study data at clinical trials meeting
+
Technology/Innovation
Amanda Rupp
| Sep 16, 2016
New data for Zinbryta support long-term safety profile
+
Technology/Innovation
Amanda Rupp
| Aug 12, 2016
Biogen launches new company dedicated to hemophilia
+
Community
Amanda Rupp
| Jun 23, 2016
McKenzie named new Biogen executive vice president
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
